Amgen Inc. Goodwill, Acquired During Period
Amgen Inc. (AMGN) reported Goodwill, Acquired During Period of $651.00 million for the 12-month period ending 2022-12-31, per its 10-K filed 2023-02-09.
Discontinued › Notes › Intangible Assets › Goodwill and Other
us-gaap:GoodwillAcquiredDuringPeriod · last filed 2023-02-09
- Amgen Inc. goodwill, acquired during period for the quarter ending 2018-12-31 was $0.00.
- Amgen Inc. goodwill, acquired during period for the quarter ending 2018-09-30 was $0.00.
- Amgen Inc. goodwill, acquired during period for the quarter ending 2018-06-30 was $0.00.
- Amgen Inc. goodwill, acquired during period for the quarter ending 2018-03-31 was $6.00M.
- Amgen Inc. goodwill, acquired during period for fiscal 2022 was $651.00M, a 159.36% increase from fiscal 2021.
- Amgen Inc. goodwill, acquired during period for fiscal 2021 was $251.00M.
- Amgen Inc. goodwill, acquired during period for fiscal 2020 was $0.00, a 100.00% decline from fiscal 2019.
- Amgen Inc. goodwill, acquired during period for fiscal 2019 was $26.00M, a 333.33% increase from fiscal 2018.
| Period end | Goodwill, Acquired During Period 3 month | Goodwill, Acquired During Period 6 month | Goodwill, Acquired During Period 9 month | Goodwill, Acquired During Period 12 month | Goodwill, Acquired During Period 12 month as first filed |
|---|---|---|---|---|---|
| 2022-12-31 | $651.00M 10-K · filed 2023-02-09 | ||||
| 2021-12-31 | $251.00M 10-K · filed 2023-02-09 | ||||
| 2020-12-31 | $0.00 10-K · filed 2022-02-16 | ||||
| 2019-12-31 | $26.00M 10-K · filed 2021-02-09 | ||||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-12 | $0.00 derived: sum of 2 quarters · filed 2020-02-12 | $0.00 derived: sum of 3 quarters · filed 2020-02-12 | $6.00M 10-K · filed 2020-02-12 | |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-31 | $0.00 derived: sum of 2 quarters · filed 2018-10-31 | $6.00M 10-Q · filed 2018-10-31 | $6.00M derived: sum of 4 quarters · filed 2018-10-31 | |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-27 | $6.00M 10-Q · filed 2018-07-27 | $6.00M derived: sum of 3 quarters · filed 2018-07-27 | $6.00M derived: sum of 4 quarters · filed 2018-07-27 | |
| 2018-03-31 | $6.00M 10-Q · filed 2018-04-25 | $6.00M derived: sum of 2 quarters · filed 2018-04-25 | $6.00M derived: sum of 3 quarters · filed 2018-04-25 | $6.00M derived: sum of 4 quarters · filed 2018-04-25 | |
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-13 | $0.00 derived: sum of 2 quarters · filed 2018-02-13 | $0.00 derived: sum of 3 quarters · filed 2018-02-13 | $0.00 10-K · filed 2018-02-13 | |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-26 | $0.00 derived: sum of 2 quarters · filed 2017-10-26 | $0.00 10-Q · filed 2017-10-26 | -$2.00M derived: sum of 4 quarters · filed 2019-02-13 | |
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-26 | $0.00 10-Q · filed 2017-07-26 | -$2.00M derived: sum of 3 quarters · filed 2019-02-13 | -$2.00M derived: sum of 4 quarters · filed 2019-02-13 | |
| 2017-03-31 | $0.00 10-Q · filed 2017-04-27 | -$2.00M derived: sum of 2 quarters · filed 2019-02-13 | -$2.00M derived: sum of 3 quarters · filed 2019-02-13 | -$2.00M derived: sum of 4 quarters · filed 2019-02-13 | |
| 2016-12-31 | -$2.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-13 | -$2.00M derived: sum of 2 quarters · filed 2019-02-13 | -$2.00M derived: sum of 3 quarters · filed 2019-02-13 | $0.00 10-K · filed 2019-02-13 | $2.00M 10-K · filed 2017-02-14 |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-26 | $0.00 derived: sum of 2 quarters · filed 2017-10-26 | $2.00M 10-Q · filed 2017-10-26 | $110.00M derived: sum of 4 quarters · filed 2017-10-26 | |
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-26 | $2.00M 10-Q · filed 2017-07-26 | $110.00M derived: sum of 3 quarters · filed 2017-07-26 | $110.00M derived: sum of 4 quarters · filed 2017-07-26 | |
| 2016-03-31 | $2.00M 10-Q · filed 2017-04-27 | $110.00M derived: sum of 2 quarters · filed 2017-04-27 | $110.00M derived: sum of 3 quarters · filed 2017-04-27 | $110.00M derived: sum of 4 quarters · filed 2017-04-27 | |
| 2015-12-31 | $108.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-14 | $108.00M derived: sum of 2 quarters · filed 2017-02-14 | $108.00M derived: sum of 3 quarters · filed 2017-02-14 | $108.00M 10-K · filed 2017-02-14 | |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-28 | $0.00 derived: sum of 2 quarters · filed 2016-10-28 | $0.00 10-Q · filed 2016-10-28 | $0.00 derived: sum of 4 quarters · filed 2016-10-31 | |
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-29 | $0.00 10-Q · filed 2016-07-29 | $0.00 derived: sum of 3 quarters · filed 2016-10-31 | $14.00M derived: sum of 4 quarters · filed 2016-10-31 | |
| 2015-03-31 | $0.00 10-Q · filed 2016-05-02 | $0.00 derived: sum of 2 quarters · filed 2016-10-31 | $14.00M derived: sum of 3 quarters · filed 2016-10-31 | $16.00M derived: sum of 4 quarters · filed 2016-10-31 | |
| 2014-12-31 | $0.00 derived: 8-K 12 month − 10-Q 9 month · filed 2016-10-31 | $14.00M derived: sum of 2 quarters · filed 2016-10-31 | $16.00M derived: sum of 3 quarters · filed 2016-10-31 | -$114.00M 8-K · filed 2016-10-31 | |
| 2014-09-30 | $14.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-02 | $16.00M derived: sum of 2 quarters · filed 2015-11-02 | -$114.00M 10-Q · filed 2015-11-02 | ||
| 2014-06-30 | $2.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-05 | -$128.00M 10-Q · filed 2015-08-05 | |||
| 2014-03-31 | -$130.00M 10-Q · filed 2015-04-27 | ||||
| 2013-12-31 | $2.40B 10-K · filed 2015-02-19 | $2.53B 10-K · filed 2014-02-24 | |||
| 2012-12-31 | $928.00M 10-K · filed 2014-02-24 | ||||
| 2011-12-31 | $435.00M 10-K · filed 2013-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GILEAD SCIENCES, INC. (GILD) | United States | $185.522B | -48.37 |
| Moderna, Inc. (MRNA) | United States | $77.819B | -8.86 |
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| BIOGEN INC. (BIIB) | United States | $33.427B | 19.60 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |